Takotsubo syndrome (TTS) has been known to occur because of emotional or physical stress, although its precise cause has not been clarified. [1] [2] [3] It has a favorable prognosis. TTS patients with cardiogenic shock due to left ventricular dysfunction, arrhythmia, or left ventricular outflow tract (LVOT) obstruction, and death caused by hemodynamic failure have been reported. 4,5 For patients with TTS accompanied with LVOT obstruction, betablockers are reported to be effective. 6,7 However, there is no report about using ultrashort-acting beta-blockers, such as landiolol hydrochloride, for treating TTS. Herein, we describe a patient in whom landiolol hydrochloride was used in the acute phase of TTS with a significant left ventricular pressure gradient caused by LVOT obstruction.
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| C A S E PRE S ENTATI ON
A 72-year-old woman presented to our emergency outpatient unit with a chief complaint of chest pain. She had precordial chest pain and shortness of breath about 5 hours before presentation following an episode of emotional stress. She had a history of hypertension. Upon physical examination, she had a fast heartbeat, blood pressure of 96/60 mm Hg, pulse rate of 100 beats/min, and systolic murmurs in the second right sternal border. She had no leg edema. 
Abstract
Takotsubo syndrome (TTS) has been known to have a favorable prognosis. Betablockers are reported to be effective for TTS patients with cardiogenic heart failure due to left ventricular outflow tract (LVOT) obstruction. However, there is no report on ultrashort-acting beta-blockers being used for treating TTS, and there are no clear guidelines for their dosages or applications. Herein, we describe a 72-year-old woman in whom landiolol hydrochloride was used in the acute phase of TTS with LVOT obstruction. In this case, the dose of landiolol hydrochloride was increased to 10 μg/kg/ min, resulting in improvement of LVOT obstruction, which led to hemodynamic stabilization. 
| D ISCUSS I ON
Mortality due to cardiogenic shock in TTS is high (17%-30%). it is an ultrashort-acting beta-blocker compared to the other betablockers. Negative inotropic effect of beta-blockers might cause further hemodynamic impairment. Ultrashort-acting beta-blockers are preferable because drug action disappears immediately after the discontinuation of the drug, especially in cases of shock. Landiolol hydrochloride is a high beta-1-selective blocker; it reduces the risk of irritation of the bronchial smooth muscle and is safer than propranolol hydrochloride. However, landiolol has a higher price than propranolol (4823 yen/50 mg vs 85 yen/2 mg).
In conclusion, this is the first case report to use ultrashort-acting beta-blockers for higher risk TTS. Further research would be needed for the appropriate use of ultrashort-acting beta-blockers in patients with TTS.
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